Australian Clinical Labs Limited (ACL.AX)

2.3700 -0.0300 (-1.25%) At close: 04:10PM AEST

Australian Clinical Labs Limited

1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
61 1 3004 53688
https://www.clinicallabs.com.au

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 5,115

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Melinda McGrath	CEO & Executive Director	1.01M	N/A	N/A
Mr. James Davison	Chief Financial Officer	540.69k	N/A	N/A
Mr. Anthony Friedli	Chief Operating Officer	N/A	N/A	N/A
Mr. Sean Jackson	Chief Information Officer	N/A	N/A	N/A
Mr. Joe Geran	National Marketing Director	N/A	N/A	N/A
Associate Prof. Tony Landgren	National Medical Director & Chief Pathologist	N/A	N/A	N/A
Mr. Chris Brownlow	Chief Executive Officer of New South Wales & Australian Capital Territory	N/A	N/A	N/A
Ms. Shae Seymour	Chief Executive Officer of Western Australia	N/A	N/A	N/A
Mr. Eric Swayn	Chief Executive Officer of South Australia & Northern Territory	N/A	N/A	N/A
Ms. Eleanor Padman B.A., FCIS	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

Corporate governance

Australian Clinical Labs Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.